SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001874944-24-000062
Filing Date
2024-05-23
Accepted
2024-05-23 16:58:18
Documents
4
Period of Report
2024-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1716497874.html 4  
1 FORM 4 wk-form4_1716497874.xml 4 3529
2 EX-24.1 chadcohen-poaxsigned.htm EX-24.1 4216
3 chadcohen-poaxsigned001.jpg GRAPHIC 191610
4 chadcohen-poaxsigned002.jpg GRAPHIC 33964
  Complete submission text file 0001874944-24-000062.txt   319970
Mailing Address C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1551 EASTLAKE AVENUE E STE 200 SEATTLE WA 98101
Business Address
Cohen Chad M (Reporting) CIK: 0001524314 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41130 | Film No.: 24979329

Mailing Address 850 NW 13TH AVENUE PORTLAND OR 097209
Business Address 850 NW 13TH AVENUE PORTLAND OR 097209 (800) 544-0300
Vacasa, Inc. (Issuer) CIK: 0001874944 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 7340 Services-To Dwellings & Other Buildings
(CF Office: 07 Trade & Services)